Belite Bio Inc ADR (BLTE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -77,611 | -52,287 | N/A | N/A |
| Depreciation Amortization | N/A | 464 | 347 | N/A | N/A |
| Other Working Capital | N/A | 3,321 | 1,517 | N/A | N/A |
| Other Operating Activity | 0 | 36,838 | 23,820 | 0 | 0 |
| Operating Cash Flow | $N/A | $-36,988 | $-26,603 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -178 | N/A | N/A | N/A |
| Purchase Of Investment | N/A | -451,994 | -95,761 | N/A | N/A |
| Sale Of Investment | N/A | 147,065 | 94,388 | N/A | N/A |
| Investing Cash Flow | $N/A | $-305,107 | $-1,373 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 546,209 | 34,867 | N/A | N/A |
| Other Financing Activity | 0 | 117,024 | 118,248 | 0 | 0 |
| Financing Cash Flow | $N/A | $663,233 | $153,115 | $N/A | $N/A |
| Exchange Rate Effect | N/A | 117 | 218 | N/A | N/A |
| Beginning Cash Position | N/A | 31,677 | 31,677 | N/A | N/A |
| End Cash Position | N/A | 352,932 | 157,034 | N/A | N/A |
| Net Cash Flow | $N/A | $321,255 | $125,357 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -36,988 | -26,603 | N/A | N/A |
| Capital Expenditure | N/A | -178 | N/A | N/A | N/A |
| Free Cash Flow | 0 | -37,166 | -26,603 | 0 | 0 |